Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MIRM stock hub

Mirum Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MIRMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MIRM

In the news

Latest news · MIRM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-335.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-8.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MIRM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001759425
Company name	Mirum Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	604749101
Employees	372
Employees Change	50%
Employees Change Percent	15.53
Enterprise value	$6.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-07-18
Isin	US6047491013
Last refreshed	2026-05-10
Market cap	$6.5B
Market cap category	Mid-Cap
Price	$107
Price currency	USD
Rev Per Employee	1,531,206.99x
Sector	Healthcare
Sic	2834
Symbol	MIRM
Website	https://www.mirumpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.22%
EV Sales Forward	9.37x
EV/Sales	11.36x
FCF yield	-2.64%
P/B ratio	26.92x
P/S ratio	11.47x
PS Forward	9.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-13.19%
EBITDA Margin	-8.79%
Gross margin	81.39%
Gross Profit	$463.6M
Gross Profit Growth	58.53%
Gross Profit Growth Q	48%
Gross Profit Growth3 Y	78.99%
Net Income	$-798.8M
Net Income Growth Years	2%
Pretax Margin	-140%
Profit Margin	-140.24%
Profit Per Employee	$-2.1M
ROA	-5.94
Roa5y	-17.92
ROCE	-12.15
ROE	-335.8
Roe5y	-58.06
ROIC	-8.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	160.14%
Cagr3y	59.85%
Cagr5y	41.84%
EPS Growth Years	3
Revenue Growth	50.19x
Revenue Growth Q	43.28x
Revenue Growth Quarters	16x
Revenue Growth Years	4x
Revenue Growth3 Y	81.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.72
Assets	$890.9M
Cash	$386.3M
Current Assets	$569.4M
Current Liabilities	$272.8M
Debt	$323.8M
Debt Equity	$1.34
Equity	$242.5M
Interest Coverage	-5.21
Liabilities	$648.4M
Long Term Assets	$321.5M
Long Term Liabilities	$375.6M
Net Cash	$62.5M
Net Cash By Market Cap	$0.96
Net Debt Equity	$-0.26
Tangible Book Value	$-11.7M
Tangible Book Value Per Share	$-0.19
WACC	6.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.09
Inventory Turnover	4.42
Net Working Capital	$-87.3M
Quick ratio	1.9
Working Capital	$296.6M
Working Capital Turnover	$1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.74%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	159.97%
200-day SMA	81.01
3Y total return	308.54%
50-day SMA	94.08
50-day SMA vs 200-day SMA	50over200
5Y total return	473.97%
All Time High	112
All Time High Change	-4.32%
All Time High Date	2026-05-07
All Time Low	6.51
All Time Low Change	1,545.32%
All Time Low Date	2019-11-20
ATR	5.54
Beta	0.52
Beta1y	0.74
Beta2y	0.73
Ch YTD	35.66
High	109.6
High52	112
High52 Date	2026-05-07
High52ch	-4.32%
Low	103.8
Low52	40
Low52 Date	2025-05-08
Low52ch	167.89%
Ma50ch	13.91%
Premarket Change Percent	1.04
Premarket Price	$104
Premarket Volume	634,233
Price vs 200-day SMA	32.28%
RSI	63.27
RSI Monthly	78.96
RSI Weekly	66.11
Sharpe ratio	2.32x
Sortino ratio	4
Total Return	-9.74%
Tr YTD	35.66
Tr1m	12.03%
Tr1w	11.01%
Tr3m	6.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	5
Analyst Price Target Top	$131
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.36
Earnings Revenue Estimate	148,169,064x
Earnings Revenue Estimate Growth	32.77x
Operating Income	$-75.1M
Operating margin	-13.19
Price target	$128
Price Target Change	$19.38
Price Target Change Top	$22.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,074,020%
Float Percent	87.03%
Shares Insiders	1.35%
Shares Institutions	89.54%
Shares Out	60,981,227
Shares Qo Q	17.24%
Shares Yo Y	9.74%
Short Float	15.48%
Short Ratio	8.6
Short Shares	13.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-264.4M
Average Volume	838,361.15x
Bv Per Share	3.98
CAPEX	$-1.6M
Ch1m	12.03
Ch1w	11.01
Ch1y	160
Ch3m	6.66
Ch3y	308.5
Ch5y	474
Ch6m	57.33
Change	4.11%
Change From Open	3.11
Close	102.9
Days Gap	0.97
Depreciation Amortization	25,066,000
Dollar Volume	189,183,907.4
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-75.1M
EBITDA	$-50.1M
EPS	$-15.17
F Score	3
FCF	$-172.6M
FCF EV Yield	-2.67x
FCF Per Share	$-2.83
Financing CF	303,862,000
Fiscal Year End	December
Founded	2,018
Income Tax	$1.4M
Investing CF	-19,389,000
Ipr	614.4
Iprfo	724.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	85.45
Ma150ch	25.41%
Ma20	97.83
Ma20ch	9.53%
Net CF	114,393,000
Next Earnings Date	2026-08-05
Open	103.9
Optionable	Yes
Position In Range	58.22
Post Close	107.2
Postmarket Change Percent	0.5
Postmarket Price	$108
Ppne	15,059,000
Pre Close	102.9
Price Date	2026-05-08
Relative Volume	2.11x
Revenue	569,609,000x
SBC By Revenue	16.12x
Share Based Comp	91,823,000
Tax By Revenue	0.24x
Tr6m	57.33%
Us State	California
Volume	1,765,434
Z Score	1.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MIRM pay a dividend?

Capital-return profile for this ticker.

Performance

MIRM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MIRM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+89.5%

Float: +87.0% of shares outstanding

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MIRM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.3

Neutral momentum band

Price vs 200-day MA

+32.3%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

2.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MIRM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MIRM stock rating?

Mirum Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MIRM analysis?

The full report lives at /stocks/MIRM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MIRM?

The latest report frames MIRM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MIRM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.